- Conditions
- Ulcerative Colitis
- Interventions
- Mirikizumab
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 1,058 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2027
- U.S. locations
- 48
- States / cities
- Dothan, Alabama • Litchfield Park, Arizona • Phoenix, Arizona + 41 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–72
of 121
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Ulcerative Colitis, IBD
- Interventions
- Brazikumab, Placebo
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 242 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2023
- U.S. locations
- 51
- States / cities
- Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 42 more
- Conditions
- Ulcerative Colitis
- Interventions
- Efavaleukin alfa, Placebo
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 221 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2024
- U.S. locations
- 63
- States / cities
- Dothan, Alabama • Homewood, Alabama • Mesa, Arizona + 57 more
- Conditions
- Ulcerative Colitis
- Interventions
- BT051 200 mg, BT051 800 mg, BT051 3200 mg, Matching Placebo
- Drug
- Lead sponsor
- Adiso Therapeutics
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 2
- States / cities
- Rialto, California • Kissimmee, Florida
- Conditions
- Ulcerative Colitis
- Interventions
- Brazikumab Maintenance Dose, Brazikumab Induction Dose
- Drug
- Lead sponsor
- AstraZeneca
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 10
- States / cities
- Chula Vista, California • Lancaster, California • Colorado Springs, Colorado + 7 more
- Conditions
- Ulcerative Colitis
- Interventions
- Vixarelimab, Placebo
- Drug
- Lead sponsor
- Genentech, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 79 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2025
- U.S. locations
- 15
- States / cities
- Camarillo, California • Los Angeles, California • Mission Hills, California + 12 more
- Conditions
- Ulcerative Colitis
- Interventions
- ABX464, Placebo
- Drug
- Lead sponsor
- Abivax S.A.
- Industry
- Eligibility
- 16 Years and older
- Enrollment
- 639 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 54
- States / cities
- Dothan, Alabama • Guntersville, Alabama • Homewood, Alabama + 45 more
- Conditions
- Ulcerative Colitis (UC)
- Interventions
- Not listed
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years to 99 Years
- Enrollment
- 8,250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2028
- U.S. locations
- 169
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 131 more
- Conditions
- Ulcerative Colitis
- Interventions
- Lutikizumab, Adalimumab
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 156 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 48
- States / cities
- Chula Vista, California • Coronado, California • Huntington Beach, California + 37 more
- Conditions
- Ulcerative Colitis
- Interventions
- Andecaliximab, Placebo
- Biological
- Lead sponsor
- Gilead Sciences
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 165 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 33
- States / cities
- Dothan, Alabama • Wheat Ridge, Colorado • Lauderdale Lakes, Florida + 30 more
- Conditions
- Ulcerative Colitis (UC)
- Interventions
- Placebo, Upadacitinib
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 16 Years to 75 Years
- Enrollment
- 1,302 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2021
- U.S. locations
- 149
- States / cities
- Birmingham, Alabama • Mobile, Alabama • Chandler, Arizona + 114 more
- Conditions
- Ulcerative Colitis
- Interventions
- tofacitinib, Placebo
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 547 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 62
- States / cities
- Tucson, Arizona • Oceanside, California • San Diego, California + 33 more
- Conditions
- Ulcerative Colitis
- Interventions
- Etrasimod, Placebo
- Drug
- Lead sponsor
- Arena Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 156 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 30
- States / cities
- Birmingham, Alabama • Dothan, Alabama • Thousand Oaks, California + 26 more
- Conditions
- Colitis, Ulcerative, Crohn Disease
- Interventions
- Mirikizumab - Intravenous (IV), Mirikizumab - Subcutaneous (SC), LY4395089
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 14
- States / cities
- Scottsdale, Arizona • Los Angeles, California • Oxnard, California + 11 more
- Conditions
- Ulcerative Colitis
- Interventions
- Etrozulimab, Placebo
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 609 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2020
- U.S. locations
- 38
- States / cities
- Birmingham, Alabama • La Jolla, California • San Diego, California + 32 more
- Conditions
- Ulcerative Colitis
- Interventions
- tofacitinib
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 118 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2029
- U.S. locations
- 19
- States / cities
- Los Angeles, California • San Francisco, California • Farmington, Connecticut + 10 more
- Conditions
- Ulcerative Colitis
- Interventions
- Efavaleukin alfa, Placebo
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 3
- States / cities
- Santa Maria, California • Kissimmee, Florida • Kansas City, Kansas
- Conditions
- Colitis, Ulcerative
- Interventions
- Guselkumab, Golimumab, JNJ-78934804, Placebo
- Biological · Drug
- Lead sponsor
- Janssen Research & Development, LLC
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 577 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2029
- U.S. locations
- 63
- States / cities
- Arcadia, California • Coronado, California • Lancaster, California + 54 more
- Conditions
- Crohn's Disease, Ulcerative Colitis
- Interventions
- Risankizumab, Trosunilimab, ABBV-701
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 2,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2031
- U.S. locations
- 55
- States / cities
- Dothan, Alabama • Phoenix, Arizona • Sun City, Arizona + 51 more
- Conditions
- Ulcerative Colitis Chronic Moderate, Ulcerative Colitis Chronic Severe
- Interventions
- PN-943, Placebo
- Drug
- Lead sponsor
- Protagonist Therapeutics, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 169 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 31
- States / cities
- Tucson, Arizona • Garden Grove, California • Los Angeles, California + 26 more
- Conditions
- Ulcerative Colitis (UC)
- Interventions
- Placebo, Upadacitinib
- Drug
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 16 Years to 75 Years
- Enrollment
- 522 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2021
- U.S. locations
- 114
- States / cities
- Mobile, Alabama • Sun City, Arizona • Tempe, Arizona + 90 more
- Conditions
- Ulcerative Colitis
- Interventions
- Etrasimod
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 12 Years to 17 Years
- Enrollment
- 36 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2033
- U.S. locations
- 20
- States / cities
- Little Rock, Arkansas • Garden Grove, California • Loma Linda, California + 8 more
- Conditions
- Ulcerative Colitis
- Interventions
- TAK-279, Placebo
- Drug
- Lead sponsor
- Takeda
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 213 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 16
- States / cities
- Los Angeles, California • Murrieta, California • Clearwater, Florida + 13 more
- Conditions
- Ulcerative Colitis
- Interventions
- Mirikizumab IV, Mirikizumab SC
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 63 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 6
- States / cities
- San Francisco, California • Atlanta, Georgia • Indianapolis, Indiana + 3 more